Cross-Hybridization in Multiplex Hybridization Reaction

Information

  • Research Project
  • 6938055
  • ApplicationId
    6938055
  • Core Project Number
    R44GM064299
  • Full Project Number
    2R44GM064299-03
  • Serial Number
    64299
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/2001 - 24 years ago
  • Project End Date
    8/31/2007 - 18 years ago
  • Program Officer Name
    PORTNOY, MATTHEW
  • Budget Start Date
    9/1/2005 - 20 years ago
  • Budget End Date
    8/31/2006 - 19 years ago
  • Fiscal Year
    2005
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/15/2005 - 20 years ago

Cross-Hybridization in Multiplex Hybridization Reaction

DESCRIPTION (provided by applicant): Multiplex hybridization of a number of nucleic acid single strands resulting in the formation of many sequence specific, individual duplex complexes, is the central process in a number of nucleic acid based diagnostic assays. Such assays are currently employed to analyze gene expression, detect genetic variations and mutations, assess viral loads in response to therapeutic agents and detect infectious pathogenic agents. Ideally, each strand present in a multiplex reaction is meant to form a duplex with only its perfectly matched and complementary single strand. In reality however, depending on the particular sequences present, many of the resident single strands can also anneal with strands other than their perfectly matched complement strand, resulting in cross-hybridization, x-hyb. X-hyb is a major nemesis of multiplex hybridization reactions causing false positive signals, lowered accuracy and sensitivity. Although x-hyb is readily acknowledged as a potential problem by all practicitioners of multiplex hybridization assay, the molecular interactions responsible for x-hyb are not understood. Other than redesigning the probes and primers and trying them again (very much a trial and error, empirical approach) there is little recourse should a given probe and/or primer set fail to function as designed [due to x-hyb]. The goal of this Phase II project is to quantitatively define sequence dependent features of x-hyb and develop a robust analytical framework for diagnosing and predicting x-hyb on the level of individual sequences. The first specific aim involves evaluation of thermodynamic parameters for tandem mismatches as a function of sequence, in solution and on microarrays, then incorporating this information in a software toolset for x-hyb analysis. The second specific aim is to apply the capabilities gained to develop RT-PCR and microarray based assays for detection of an alternatly spliced variant of the Creld1 gene, the (exon 9b) isoform, whose presence has been has been linked to various cancers.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    490692
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:490692\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PORTLAND BIOSCIENCE
  • Organization Department
  • Organization DUNS
    146613133
  • Organization City
    PORTLAND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    97201
  • Organization District
    UNITED STATES